AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Feb 10, 2015
29821_dirs_2015-02-10_e5092c85-b403-48bb-9419-7a260feeb5bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-06
Reporting Person: Ballinger Kevin J. (SVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-06 | Common Stock | S | 21408.0000 | $15.0579 | Disposed | 28440.0000 | Direct |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.0500 to $15.0920, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.